Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
Active substance factsheet - Last updated: 25/06/2024
Medetomidine
Substance name:
EC number:
811-718-6
CAS number:
86347-14-0
IUPAC name:
5-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole
BAS number:
1327
Product-type:
PT21
Candidate for substitution:
Yes
Regulatory categorisation:
Substance not in Review Programme
Approval/Assessment status:
Approved
-
Renewal in progress
Commission decision
No related authorised products are available
Evaluating competent authority:
Norway
R4BP asset number:
EU-0012188-0000
Legal act:
Start date:
01/01/2016
End date:
30/06/2025
Assessment Report
N/A
Study summary
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
BPC opinions
N/A
Medetomidine_PT_21_Final_BPC_opinion.pdf (en) (24/06/2024)
Evaluating competent authority:
Norway
Assessment outcome:
In progress
Conclusion date:
BPC opinions
Medetomidine_PT_21_Final_BPC_opinion.pdf (en) (24/06/2024)
Evaluating competent authority:
-
Assessment outcome:
Successful
Conclusion date:
31/10/2022
Assessment Report
N/A
Study summary
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
BPC opinions
N/A
Evaluating competent authority:
-
Assessment outcome:
Successful
Conclusion date:
02/04/2019
Assessment Report
N/A
Study summary
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
BPC opinions
N/A
Evaluating competent authority:
United Kingdom
Assessment outcome:
Successful
Conclusion date:
08/10/2015
Assessment Report
N/A
Study summary
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A